New Key Statistics Module, Z-Score and F-Score
NAS:FULC Key Ratios
| Market Cap $ M | 261.06 |
| Enterprise Value $ M | -2.67 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.99 |
| Price/Sales | 3.81 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 80.00 |
| EPS (TTM) $ | -0.31 |
| Beneish M-Score | 22.97 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 10.60 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.46 |
| EV-to-EBITDA | -0.49 |
| PEG | -- |
| Shares Outstanding M | 53.94 |
| Net Margin (%) | -22.15 |
| Operating Margin % | -35.11 |
| Pre-tax Margin (%) | -22.15 |
| Quick Ratio | 18.44 |
| Current Ratio | 18.44 |
| ROA % (ttm) | -6.67 |
| ROE % (ttm) | -7.25 |
| ROIC % (ttm) | -167.27 |
| Dividend Yield % | -- |
| Altman Z-Score | 5.86 |
FULC Number of Guru Trades
FULC Volume of Guru Trades
Gurus Latest Trades with NAS:FULC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:FULC is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Fulcrum Therapeutics Inc Insider Transactions
No Available Data
News about NAS:FULC
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers